0000899243-17-009487.txt : 20170405 0000899243-17-009487.hdr.sgml : 20170405 20170405160604 ACCESSION NUMBER: 0000899243-17-009487 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170403 FILED AS OF DATE: 20170405 DATE AS OF CHANGE: 20170405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prothena Corp plc CENTRAL INDEX KEY: 0001559053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ADELPHI PLAZA STREET 2: UPPER GEORGE'S STREET CITY: DUN LAOGHAIRE, CO. DUBLIN STATE: L2 ZIP: A96 T927 BUSINESS PHONE: 011-353-1-236-2500 MAIL ADDRESS: STREET 1: ADELPHI PLAZA STREET 2: UPPER GEORGE'S STREET CITY: DUN LAOGHAIRE, CO. DUBLIN STATE: L2 ZIP: A96 T927 FORMER COMPANY: FORMER CONFORMED NAME: Neotope Corp Ltd DATE OF NAME CHANGE: 20120926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Selkoe Dennis J. CENTRAL INDEX KEY: 0001582306 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35676 FILM NUMBER: 17742603 MAIL ADDRESS: STREET 1: 650 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-03 0 0001559053 Prothena Corp plc PRTA 0001582306 Selkoe Dennis J. C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Ordinary Shares, par value $0.01 per share 2017-04-03 4 M 0 3500 16.42 A 6345 D Ordinary Shares, par value $0.01 per share 2017-04-03 4 S 0 3500 55.8637 D 2845 D Ordinary Shares, par value $0.01 per share 1363 I By wife Stock Option (right to buy) 16.42 2017-04-03 4 M 0 3500 0.00 D 2014-07-22 2023-07-21 Ordinary Shares 3500 10500 D The sale reported on this Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. The transaction was executed in multiple trades in prices ranging from $55.39 to $56.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. /s/ A.W. Homan, as Attorney-in-Fact for Dennis J. Selkoe 2017-04-05